Parkside Financial Bank & Trust’s Enanta Pharmaceuticals ENTA Stock Holding History

Parkside Financial Bank & Trust’s Portfolio ENTA Stock Details ENTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$897	Hold	71	–	–	﹤0.01%	2390
2025 Q4	$1.12K	Hold	71	–	–	﹤0.01%	2307
2025 Q3	$850	Hold	71	–	–	﹤0.01%	2351
2025 Q2	$897	Buy	+71	New	+$427	﹤0.01%	2305
2023 Q3	–	Sell	-140	Closed	-$3K	–	2063
2023 Q2	$3K	Buy	140 +96	+218%	+$2.83K	﹤0.01%	1555
2023 Q1	$1.78K	Hold	44	–	–	﹤0.01%	1734
2022 Q4	$2.05K	Sell	44 -15	-25%	-$684	﹤0.01%	1675
2022 Q3	$3K	Buy	59 +57	+2,850%	+$3.33K	﹤0.01%	1393
2022 Q2	$0	Sell	2 -59	-97%	-$3.2K	﹤0.01%	1846
2022 Q1	$4K	Sell	61 -5	-8%	-$325	﹤0.01%	1366
2021 Q4	$5K	Hold	66	–	–	﹤0.01%	1300
2021 Q3	$4K	Sell	66 -2	-3%	-$99	﹤0.01%	1316
2021 Q2	$3K	Buy	68 +6	+10%	+$294	﹤0.01%	1410
2021 Q1	$3K	Buy	62 +35	+130%	+$1.75K	﹤0.01%	1369
2020 Q4	$1K	Sell	27 -15	-36%	-$660	﹤0.01%	1512
2020 Q3	$2K	Hold	42	–	–	﹤0.01%	1152
2020 Q2	$2K	Hold	42	–	–	﹤0.01%	1151
2020 Q1	$2K	Buy	42 +23	+121%	+$1.23K	﹤0.01%	1096
2019 Q4	$1K	Sell	19 -7	-27%	-$434	﹤0.01%	1366
2019 Q3	$2K	Hold	26	–	–	﹤0.01%	1143
2019 Q2	$2K	Hold	26	–	–	﹤0.01%	1161
2019 Q1	$2K	Buy	26 +13	+100%	+$1.17K	﹤0.01%	1151
2018 Q4	$1K	Hold	13	–	–	﹤0.01%	1199
2018 Q3	$1K	Hold	13	–	–	﹤0.01%	1247
2018 Q2	$2K	Hold	13	–	–	﹤0.01%	1047
2018 Q1	$1K	Hold	13	–	–	﹤0.01%	1166
2017 Q4	$1K	Hold	13	–	–	﹤0.01%	1114
2017 Q3	$1K	Hold	13	–	–	﹤0.01%	1112
2017 Q2	$0	Hold	13	–	–	﹤0.01%	1440
2017 Q1	$0	Buy	+13	New	+$405	﹤0.01%	1394

Other funds holding ENTA

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

SSC

Spruce Street Capital New York $416M AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Parkside Financial Bank & Trust's ENTA Position: Q1 2026 in Review

Parkside Financial Bank & Trust held its Enanta Pharmaceuticals (ENTA) position steady in Q1 2026 at 71 shares worth $897. The position accounts for ﹤0.01% of the portfolio, ranked #2390.

Parkside Financial Bank & Trust first reported a position in ENTA in Q1 2017 and has held it in 30 quarters since. The position peaked at $5K in Q4 2021. 133 funds tracked by Wall St. Rank hold ENTA as of Q1 2026.

Parkside Financial Bank & Trust held 71 shares of Enanta Pharmaceuticals worth $897 as of Q1 2026.
Parkside Financial Bank & Trust left its Enanta Pharmaceuticals share count unchanged in Q1 2026.
Enanta Pharmaceuticals made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #2390 holding.
Parkside Financial Bank & Trust first reported a position in Enanta Pharmaceuticals in Q1 2017 and has held it in 30 quarters since.
Parkside Financial Bank & Trust's Enanta Pharmaceuticals position peaked at $5K in Q4 2021.
133 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.